<SEC-DOCUMENT>0001193125-17-069744.txt : 20170303
<SEC-HEADER>0001193125-17-069744.hdr.sgml : 20170303
<ACCEPTANCE-DATETIME>20170303160815
ACCESSION NUMBER:		0001193125-17-069744
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20170303
DATE AS OF CHANGE:		20170303
EFFECTIVENESS DATE:		20170303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tokai Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001404281
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-216432
		FILM NUMBER:		17663643

	BUSINESS ADDRESS:	
		STREET 1:		255 STATE STREET
		STREET 2:		6TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		617-225-4348

	MAIL ADDRESS:	
		STREET 1:		255 STATE STREET
		STREET 2:		6TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d252102ds8.htm
<DESCRIPTION>S-8
<TEXT>
<HTML><HEAD>
<TITLE>S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on March&nbsp;3, 2017 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-8</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>TOKAI PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">20-1000967</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Incorporation or Organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>255 State Street, 6th floor</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boston, Massachusetts 02109</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>02142</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014 Stock Incentive Plan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014 Employee Stock Purchase Plan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full Title of the Plan) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Jodie P. Morrison </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>President and Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Tokai Pharmaceuticals, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>255 State Street, 6th floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boston, Massachusetts 02109 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name and Address of Agent For Service) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT STYLE="white-space:nowrap">225-4305</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Telephone Number, Including Area Code, of Agent For Service) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, or a smaller reporting company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule 12b of the Exchange Act. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:0pt;margin-bottom:0pt;page-break-before:always"></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of Securities</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be Registered</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registered
(1)</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering
Price</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Per Share</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Maximum<BR>Aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering Price</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount of<BR>Registration Fee</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, $0.001 par value per share</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">1,132,082&nbsp;shares&nbsp;(2)</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$0.80(3)</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$905,665.60(3)</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$105.00</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">In accordance with Rule 416 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this registration statement shall be deemed to cover any additional securities that may from time to time be
offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i) 905,666 additional shares authorized for issuance under the 2014 Stock Incentive Plan (the &#147;2014 Plan&#148;); and (ii)&nbsp;226,416 additional shares authorized for issuance under the 2014 Employee
Stock Purchase Plan (the &#147;ESPP&#148;). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)<B></B></TD>
<TD ALIGN="left" VALIGN="top"><B></B>Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the Registrant&#146;s Common
Stock as reported on the NASDAQ Global Market on March&nbsp;2, 2017. </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8,</FONT> relating to the 2014 Stock Incentive Plan (the &#147;2014
Plan&#148;) of Tokai Pharmaceuticals, Inc. (the &#147;Registrant&#148;) and the 2014 Employee Stock Purchase Plan (the &#147;ESPP&#148;) of the Registrant, is being filed for the purpose of registering additional securities of the same class as
other securities for which a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> has previously been filed and is effective. Accordingly, this Registration Statement incorporates by reference the contents of (i)&nbsp;the
Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8,</FONT> File <FONT STYLE="white-space:nowrap">No.&nbsp;333-200413,</FONT> filed with the Securities and Exchange Commission on November&nbsp;20, 2014 by the Registrant, relating to
the 2014 Plan and the ESPP, (ii)&nbsp;the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8,</FONT> File <FONT STYLE="white-space:nowrap">No.&nbsp;333-203032,</FONT> filed with the Securities and Exchange Commission on
March&nbsp;26, 2015 by the Registrant, relating to the 2014 Plan, and (iii)&nbsp;the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8,</FONT> File <FONT STYLE="white-space:nowrap">No.&nbsp;333-210058,</FONT> filed with the
Securities and Exchange Commission on March&nbsp;10, 2016 by the Registrant, relating to the 2014 Plan, in each case except for Item 8, Exhibits, with respect to which the Exhibit Index immediately preceding the exhibits attached hereto is
incorporated herein by reference. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on Form <FONT STYLE="white-space:nowrap">S-8</FONT> and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston,
Commonwealth of Massachusetts, on this 3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> day of March, 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOKAI PHARMACEUTICALS, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jodie P. Morrison</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jodie P. Morrison</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY AND SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, the undersigned officers and directors of Tokai Pharmaceuticals, Inc., hereby severally constitute and appoint Jodie P. Morrison and John
S. McBride, and each of them singly, our true and lawful attorneys with full power to any of them, and to each of them singly, to sign for us and in our names in the capacities indicated below the Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-8</FONT> filed herewith and any and all amendments to said Registration Statement, and generally to do all such things in our name and on our behalf in our capacities as officers and directors to enable Tokai
Pharmaceuticals, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said
attorneys, or any of them, to said registration statement and any and all amendments thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the
Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:15.95pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:16.00pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jodie P. Morrison</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jodie P. Morrison</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">President, Chief Executive</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Officer and Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;3, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John S. McBride</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">John S. McBride</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Financial Officer and</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Operating Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Principal Financial and Accounting Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;3, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Seth L. Harrison</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seth L. Harrison</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chairman of the Board</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;3, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen Buckley, Jr.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen Buckley, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;3, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cheryl L. Cohen</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cheryl L. Cohen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;3, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David A. Kessler</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David A. Kessler</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;3, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph A. Yanchik, III</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph A. Yanchik, III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;3, 2017</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Restated Certificate of Incorporation of the Registrant</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.2(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Bylaws of the Registrant</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Opinion of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Registrant</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Consent of Wilmer Cutler Pickering Hale and Dorr LLP (included in Exhibit 5.1)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Power of attorney (included on the signature pages of this registration statement)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2014 Stock Incentive Plan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2014 Employee Stock Purchase Plan</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Previously filed with the Securities and Exchange Commission on September&nbsp;26, 2014 as Exhibit 3.1 to the Registrant&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;001-36620)</FONT> and incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Previously filed with the Securities and Exchange Commission on September&nbsp;26, 2014 as Exhibit 3.2 to the Registrant&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;001-36620)</FONT> and incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Previously filed with the Securities and Exchange Commission on September&nbsp;2, 2014 as Exhibit 10.5 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as amended
(File <FONT STYLE="white-space:nowrap">No.&nbsp;333-198052),</FONT> and incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Previously filed with the Securities and Exchange Commission on September&nbsp;2, 2014 as Exhibit 10.17 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as amended
(File <FONT STYLE="white-space:nowrap">No.&nbsp;333-198052),</FONT> and incorporated herein by reference. </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d252102dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g252102g0228124535542.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">+1 617 526 6000 (t) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">+1 617 526 5000 (f) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">wilmerhale.com
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;3, 2017 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tokai Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">255 State Street, 6th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts 02109 </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top">2014 Stock Incentive Plan </TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">2014 Employee Stock Purchase Plan </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assisted in the
preparation of a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (the &#147;Registration Statement&#148;) to be filed with the Securities and Exchange Commission (the &#147;Commission&#148;) under the Securities Act of
1933, as amended (the &#147;Securities Act&#148;), relating to an aggregate of 1,132,082 additional shares of common stock, $0.001 par value per share (the &#147;Shares&#148;), of Tokai Pharmaceuticals, Inc., a Delaware corporation (the
&#147;Company&#148;), consisting of (i) 905,666 shares issuable under the Company&#146;s 2014 Stock Incentive Plan (the &#147;2014 Plan&#148;) and (ii) 226,416 shares issuable under the Company&#146;s Employee Stock Purchase Plan (the
&#147;ESPP&#148;) . </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have examined the Certificate of Incorporation and <FONT STYLE="white-space:nowrap">By-Laws</FONT> of the Company,
each as amended and restated to date, and originals, or copies certified to our satisfaction, of all pertinent records of the meetings of the directors and stockholders of the Company, the Registration Statement and such other documents relating to
the Company as we have deemed material for the purposes of this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our examination of the foregoing documents, we have assumed
the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, photostatic or other copies, the authenticity of the originals of
any such documents and the legal competence of all signatories to such documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We assume that the appropriate action will be taken,
prior to the offer and sale of the Shares in accordance with the Plan and the ESPP, to register and qualify the Shares for sale under all applicable state securities or &#147;blue sky&#148; laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We express no opinion herein as to the laws of any state or jurisdiction other than the state laws of the Commonwealth of Massachusetts, the
General Corporation Law of the State of Delaware and the federal laws of the United States of America. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is understood that this opinion
is to be used only in connection with the offer and sale of the Shares while the Registration Statement is in effect. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; text-indent:6%">


<IMG SRC="g252102g0228124535635.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g252102g0228124535542.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 3, 2017 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please note that we are opining only as to the matters expressly set
forth herein, and no opinion should be inferred as to any other matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing, we are of the opinion that the Shares
have been duly authorized for issuance and, when the Shares are issued and paid for in accordance with the terms and conditions of the Plan, the Shares will be validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion with the Commission in connection with the Registration Statement in accordance with the
requirements of Item 601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7
of the Securities Act or the rules and regulations of the Commission. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WILMER CUTLER PICKERING</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">HALE AND
DORR LLP</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stuart M. Falber</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stuart M. Falber, Partner</P></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d252102dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form&nbsp;S-8 of our report dated March&nbsp;3, 2017 relating to the
financial statements, which appears in Tokai Pharmaceuticals, Inc.&#145;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ PricewaterhouseCoopers LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, MA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;3, 2017 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g252102g0228124535542.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g252102g0228124535542.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  0 'P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#L-2TG3O"G
MQ3L;TV%J-(\0Q&QF0PKLCN!@KQC W\#'<Y)K'LM"M[3Q-K'P]>PC-I?7L6I0
MRF,?+:\LZ@]>"OECO\[&O0_'GAX^)?"%[8Q9%VB^?:,."LR<K@]L]/QKSBZN
M-;NM&T?XGO;2&_M)(HC9J<;[4CRWX]6D9F'H"/2@#IM7TJS;4=7UC3[*R@_X
M1VP:.T/V92GG[?-;C_941@>A9L8-1ZEXKUVS^#L/BQ+J Z@8HIV4P#RR'=5V
MXSGC=G.:W;VQETOX:ZC;3*\U]-93M-Y49=I+B56+8 R3EV('MBN-UB*XF_9[
M@TN.RO7U V\$/V86LGF;TD0L"NW(P >>E 'J4"73Z5&K77^E-&,SB,8W'OMZ
M?A7)_#3Q??>*-,O(]76)-3M)%+K&NT-%(@>-L9[C/Y5I-XKM4LK=(+349':$
ME\V,R^4 A/.4Y)("@#G)]C7%)H&J&?PO>Z/'- NI:8FDZMNC9&B58P=^" 0X
M"NH)[[?6@#H?"GBK4?$WB_Q%:^8D.FV(A^R!8@6D6120Y8]CC<..C"JGA_7/
M$NN:/K-R=6LH+BRU*6P@5[4;)&4J$W'=P69@./6G>&BMC\3/%K_9+F&QD@M5
MMY/LSB-A#$58*<8..G'X5A^#K31H(M9NM:T>]CO%UR6]MICIDQD,8970JP0\
M$@\>Y]: .JUS6-:A^(>DZ#9WT,%I?VTLI+6X=D9!ZYY!K)_MJ;Q7\/O&5MK5
MG:R7&D&[MO.BC_=R/&C8D4'.UA]>*@\00GQ!\0O#,ES9:E;V[Z=*MP\22J;=
MY4^53(HP&&?7'K4%A+J'A_P%K_A#4]-NVNK>VN(K*XMK-W2]1U;:<H"-^3@Y
MY]>] &EX!U_PI8_#_2K.;4--A=[5?M,3,HW.1AMX[D]\U!\'X-.$/BB]M(K<
M+_;5Q'%,B@?N1M*J#_=[XZ5T?P_F\GX?:5'/#<02VEJL<\<T#HRLHY^4C)_"
MN%T"[N;;P_XKL?L>I03ZMK<ODN;&4;8)BJF7.WC"[C]0* .N\#^,KKQ'J^N6
M5]"L)@>.XL@%P7M9%RC>YQ@G_>Q4OAO6M6O_ !SXETF[NHI+32C (@L(5G\Q
M"WS'/;&.*P[_ $M_"/Q'T#4[/^T;RTN+5[&]/E-+Y,8P8S\J\ -^@J7P]J":
M?\1O&=Y=6NH):WC6IMYA8S,LFR,JV"%[$T :NL:QK,7Q%TS0;2]BAL[VTDG8
MM;AV1D[ Y'!]ZZ+16O6MIOMMW!=D3LL4T*; R# P1DX(;<#]*\ZUBXM==^(O
MA_4+[1+V334M)TE$VGRR*A)/EEAL."0 <=L\UT=KKHTJW&GZ!X=O[JPMR55V
21H0I)+%5#J"5&X '\.U '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g252102g0228124535635.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g252102g0228124535635.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ; FT# 2(  A$! Q$!_\0
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M],5 VCV#HJO;[R)%E#L[%]RC .XG/ )'7H2* ,>]\5RVZZF(K*-WLXHY%S<
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ML(2MX29U(^5R<$G'0$D DCDD T_^QK#,3"W7?%&\2,22=K8W Y^\#@'G/(H
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MQTY/K0!DOXDN$M&E?2Y5=' <,) H7:6W9,>>V/NX'<XKH%8,H92"",@BJ/\
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MDGB&9$F L5,MLC/<+Y^ H#%1M.WYL[2>W'OQ6PUI;M(9&@C+D[BQ7G/R\_\
MCB_]\CTKCO&!$>NZ/;K''Y5Q)B4&-23NDC!Y(R,Y/3V]!0!L?V_=QP322V,1
M,'GR2;)SQ%&Y7(RO+'!XX''49JOJ?BY]+V/+IK/%)++'&4F&X^6VTD@CC/;D
M_A6U)I.GRG,EI$WSL_*]VP6_ D D="1FG7&EV%TJK<6<$H0LRAT!P6.6/XF@
##__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
